Rallybio Corp Company Insiders
| RLYB Stock | USD 4.70 0.05 1.05% |
Rallybio Corp employs about 15 people. The company is managed by 6 executives with a total tenure of roughly 35 years, averaging almost 5.0 years of service per executive, having 2.5 employees per reported executive. Analysis of Rallybio Corp's management performance can provide insight into the company performance.
Rallybio Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.2835) % which means that it has lost $0.2835 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2117) %, meaning that it created substantial loss on money invested by shareholders. Rallybio Corp's management efficiency ratios could be used to measure how well Rallybio Corp manages its routine affairs as well as how well it operates its assets and liabilities.The market capitalization of Rallybio Corp is $25.08 Million. Over half of Rallybio Corp's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Some institutional investors establish a significant position in stocks such as Rallybio Corp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Rallybio Corp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Rallybio Corp Workforce Comparison
Rallybio Corp is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 170. Rallybio Corp holds roughly 15.0 in number of employees claiming about 9% of equities under Health Care industry.
Rallybio Corp Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rallybio Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rallybio Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Rallybio Corp insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Rallybio Corp Notable Stakeholders
A Rallybio Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Rallybio Corp often face trade-offs trying to please all of them. Rallybio Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Rallybio Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Martin MacKay | CoFounder Chairman | Profile | |
| MD MB | President, CoFounder | Profile | |
| Jonathan MBA | CFO Treasurer | Profile | |
| Ami Bavishi | Head Communications | Profile | |
| Jeffrey CPA | CFO CoFounder | Profile | |
| MD FACP | Chief Officer | Profile |
About Rallybio Corp Management Performance
The success or failure of an entity such as Rallybio Corp often depends on how effective the management is. Rallybio Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Rallybio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Rallybio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut. Rallybio Corporaton operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 45 people.
Please note, the presentation of Rallybio Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Rallybio Corp's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Rallybio Corp's management manipulating its earnings.
Rallybio Corp Workforce Analysis
Traditionally, organizations such as Rallybio Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Rallybio Corp within its industry.Rallybio Corp Manpower Efficiency
Return on Rallybio Corp Manpower
| Revenue Per Employee | 42.4K | |
| Revenue Per Executive | 106K | |
| Net Loss Per Employee | 3.9M | |
| Net Loss Per Executive | 9.6M | |
| Working Capital Per Employee | 4.1M | |
| Working Capital Per Executive | 10.3M |
Complementary Tools for Rallybio Stock analysis
When running Rallybio Corp's price analysis, check to measure Rallybio Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rallybio Corp is operating at the current time. Most of Rallybio Corp's value examination focuses on studying past and present price action to predict the probability of Rallybio Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rallybio Corp's price. Additionally, you may evaluate how the addition of Rallybio Corp to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |